What Researchers Did
Researchers conducted a combined prospective and retrospective observational trial to evaluate the effectiveness of hyperbaric oxygen treatment (HBOT) in improving symptoms and signs of pelvic late radiation tissue injury.
What They Found
Fifty-two patients with pelvic late radiation tissue injury received HBOT, leading to a statistically significant reduction in mean LENT-SOMA scores from 11.7 to 8.1 (P < 0.001). Specifically, mean scores for radiation cystitis decreased by 3.7 (P < 0.001) and for radiation proctitis by 3.8 (P = 0.004). No significant adverse effects were recorded during the treatment.
What This Means for Canadian Patients
Canadian patients suffering from pelvic late radiation tissue injury following radiotherapy may find hyperbaric oxygen treatment to be a safe and effective option for symptom relief. This treatment could potentially improve their quality of life by mitigating the discomfort associated with radiation side effects.
Canadian Relevance
This study has no direct Canadian connection as it was not conducted in Canada or with Canadian participants.
Study Limitations
The observational and retrospective design, coupled with a relatively small sample size, limits the generalizability and causal conclusions of these findings.